Insider Buying: Arcus Biosciences Inc (RCUS) CEO Purchases 66,666 Shares of Stock (RegistrarJournal.com)
Arcus Biosciences Inc (NYSE:RCUS) CEO Terry J. Rosen acquired 66,666 shares of Arcus Biosciences stock in a transaction dated Monday, March 19th. The stock was purchased at an average cost of $15.00 per share, for a total transaction of $999,990.00. The purchase was disclosed in a filing with the Securities & Exchange Commission.
Insider Buying: SCYNEXIS Inc (NASDAQ:SCYX) CEO Acquires 100,000 Shares of Stock (StockNewsTimes.com)
SCYNEXIS Inc (NASDAQ:SCYX) CEO Marco Taglietti purchased 100,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 8th. The shares were bought at an average cost of $1.69 per share, for a total transaction of $169,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 404,000 shares in the company, valued at approximately $682,760. The transaction was disclosed in a document filed with the SEC.
Insider Buying: RealNetworks Inc (RNWK) CFO Buys 35,816 Shares of Stock (LedgerGazette.com)
RealNetworks Inc (NASDAQ:RNWK) CFO Cary Baker acquired 35,816 shares of the stock in a transaction dated Thursday, March 1st. The shares were purchased at an average price of $2.93 per share, for a total transaction of $104,940.88. Following the completion of the transaction, the chief financial officer now owns 18,266 shares of the company’s stock, valued at approximately $53,519.38. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Insider Buying: Appian Corp (NASDAQ:APPN) Major Shareholder Buys $712,525.00 in Stock (StockNewsTimes.com)
Appian Corp (NASDAQ:APPN) major shareholder Abdiel Capital Management, Llc acquired 27,500 shares of the firm’s stock in a transaction that occurred on Thursday, March 15th. The stock was acquired at an average price of $25.91 per share, for a total transaction of $712,525.00. The purchase was disclosed in a filing with the Securities & Exchange Commission.
Insider Selling: Heron Therapeutics Inc (HRTX) VP Sells 18,000 Shares of Stock (LedgerGazette.com)
Heron Therapeutics Inc (NASDAQ:HRTX) VP Kimberly Manhard sold 18,000 shares of Heron Therapeutics stock in a transaction that occurred on Monday, March 19th. The stock was sold at an average price of $30.00, for a total value of $540,000.00. Following the sale, the vice president now directly owns 18,000 shares of the company’s stock, valued at $540,000. The transaction was disclosed in a document filed with the SEC.
Insider Buying: Stellus Capital Investment Corp (NYSE:SCM) Insider Buys 10,000 Shares of Stock (RegistrarJournal.com)
Stellus Capital Investment Corp (NYSE:SCM) insider Robert T. Ladd acquired 10,000 shares of the company’s stock in a transaction dated Friday, March 16th. The shares were acquired at an average price of $11.68 per share, for a total transaction of $116,800.00. The transaction was disclosed in a filing with the Securities & Exchange Commission.
